Boult Wade Tennant
People » Dr Barbara Rigby

Dr Barbara Rigby

Partner

Cambridge

Contact
Download V-card
Address
Memberships
  • CIPA, member of CIPA Life Sciences Committee
  • EPI
Qualifications
  • Registered UPC Representative
  • European Patent Attorney
  • Chartered Patent Attorney
  • Intellectual Property (Basic) Litigation Certificate
  • Certificate in Intellectual Property Law, Queen Mary University of London
  • PhD Microbial Biochemistry and Genetics, University of Warwick
  • MA (Cantab) Natural Sciences, University of Cambridge
  • Registered UPC Representative

With extensive experience working in the biotechnology and pharmaceutical IP fields, I support clients ranging from start-ups to major multinationals. They know they can rely on me to provide clear, commercially-focused advice, handle all aspects of their patent portfolios and tailor a strategy that helps their business to thrive.

My practice allows me to draw on my passion for science, covering a wide range of biotech and pharma innovation, including diagnostic technologies, vaccines, biopharmaceuticals, micro-organisms, cosmetics and stem cells. I have expertise in the fields of antibodies and CRISPR technology.

Working with clients of all sizes, including start-up companies, SMEs and multinationals, I enjoy gaining a clear understanding of their business and working with them towards achieving their objectives.

I support clients at all stages of their business, from guiding them through the IP process and building a strong patent strategy to protect and exploit their inventions through to supporting the launch of their commercial products.

I have extensive experience of drafting and worldwide prosecution and management of patent portfolios. On the other side of the coin, my practice includes both attacking and defending patents during Opposition and Appeal Proceedings before the European Patent Office, often in multi-party proceedings.

I am also frequently called upon to provide freedom to operate (FTO) advice, coordinating with experts across multiple jurisdictions where activities span the globe. My expertise further includes carrying out due diligence for acquisitions and providing strategic advice on SPC applications.

As an active member for the CIPA Life Sciences Committee, I relish the opportunity to exchange experiences with other members and influence policy. Through IP Inclusive I am also a mentor to young people aspiring to join the profession.

Recent experience

Devising an IP strategy for medtech start-up 52 North Health, drafting and filing its first patent application.

Supporting a client in relation to an alleged infringement, analysing multi-jurisdictional issues of validity and infringement and providing tailored advice on strategic options.

Providing freedom-to-operate advice to Abcam in relation to an early stage project, including performing targeted searches, advising on patent term extensions and identifying potential opportunities.

Testimonials and recognitions
  • “For me the stand-out team members are Matthew Spencer and Barbara Rigby. I am impressed by their attention to detail, diligence and willingness to rise to challenges, such as tight deadlines or less than ideal information provided by the client.” Client quote, Legal 500, 2022
  • Recognised as a key attorney by The Legal 500 in 2020
Relevant Search Terms
Recommended Sites
Suggested Media
Recognitions
Additional Info
Languages
  • German
“I support clients at all stages of their business, from guiding them through the IP process and building a strong patent strategy to protect and exploit their inventions through to supporting the launch of their commercial products.”
Sector Experience
Biotechnology
  • Antibody engineering
  • Antibody manufacture and formulation
  • Bioinformatics
  • Biosimilars
  • Gene editing (e.g. CRISPR)
  • Genomic and molecular tools and methods
  • Immuno-oncology (e.g. checkpoint inhibitors; modified T cells)
  • Next generation sequencing
  • Nucleic acid synthesis
  • Recombinant protein production and purification
  • Stem cell therapies
  • Synthetic biology
  • Therapeutic antibodies
  • Vaccinology (e.g. viral vectors; mRNA vaccines)
  • Women’s health products
Energy and green technologies
  • Biofuels
Food and beverage
Medical devices and diagnostics 
  • In vitro diagnostics
  • Medtech
Pharmaceuticals
  • Diagnostics
  • Generic market entry
  • Personalised medicine/disease biomarkers
  • Pharmaceutical formulations

With extensive experience working in the biotechnology and pharmaceutical IP fields, I support clients ranging from start-ups to major multinationals. They know they can rely on me to provide clear, commercially-focused advice, handle all aspects of their patent portfolios and tailor a strategy that helps their business to thrive.

My practice allows me to draw on my passion for science, covering a wide range of biotech and pharma innovation, including diagnostic technologies, vaccines, biopharmaceuticals, micro-organisms, cosmetics and stem cells. I have expertise in the fields of antibodies and CRISPR technology.

Working with clients of all sizes, including start-up companies, SMEs and multinationals, I enjoy gaining a clear understanding of their business and working with them towards achieving their objectives.

I support clients at all stages of their business, from guiding them through the IP process and building a strong patent strategy to protect and exploit their inventions through to supporting the launch of their commercial products.

I have extensive experience of drafting and worldwide prosecution and management of patent portfolios. On the other side of the coin, my practice includes both attacking and defending patents during Opposition and Appeal Proceedings before the European Patent Office, often in multi-party proceedings.

I am also frequently called upon to provide freedom to operate (FTO) advice, coordinating with experts across multiple jurisdictions where activities span the globe. My expertise further includes carrying out due diligence for acquisitions and providing strategic advice on SPC applications.

As an active member for the CIPA Life Sciences Committee, I relish the opportunity to exchange experiences with other members and influence policy. Through IP Inclusive I am also a mentor to young people aspiring to join the profession.

Recent experience

Devising an IP strategy for medtech start-up 52 North Health, drafting and filing its first patent application.

Supporting a client in relation to an alleged infringement, analysing multi-jurisdictional issues of validity and infringement and providing tailored advice on strategic options.

Providing freedom-to-operate advice to Abcam in relation to an early stage project, including performing targeted searches, advising on patent term extensions and identifying potential opportunities.

Testimonials and recognitions
  • “For me the stand-out team members are Matthew Spencer and Barbara Rigby. I am impressed by their attention to detail, diligence and willingness to rise to challenges, such as tight deadlines or less than ideal information provided by the client.” Client quote, Legal 500, 2022
  • Recognised as a key attorney by The Legal 500 in 2020
Relevant Search Terms
Recommended Sites
Suggested Media
Recognitions
Additional Info

Insights

image
Bulletin

EPO Board of Appeal aims to clarify the correct approach to claim interpretation when assessing patentability

Mehr
image
Bulletin

Neurim Overturned – CJEU severely restricts availability of second medical use SPCs

Mehr
image
Bulletin

G1/23 – A burdensome new referral to the EPO’s Enlarged Board regarding the state of the art.

Mehr
image
Bulletin

Proposals for reform of the EU’s SPC system.

Mehr
image
Bulletin

Criteria for basing SPCs on functional claims clarified by CJEU in Royalty Pharma

Mehr
INSIGHTS